NFKB1 and triple-A syndrome: The engagement of RAGE with its ligands evokes the generation of intracellular ROS and results in the activation of MAPK and NF-κB signaling, which then triggers the release of inflammatory factors, cytokines, and chemokines, thereby contributing to the development and progression of AAA [9].